ValiRx - Extension of Collaboration Agreement
VAL Mon, 15 Feb 2021, 12:00pm GMT
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Dr Suzy Dilly, Chief Executive Officer, discusses the recently announced agreement with Physiomics plc. ValiRx is pleased to be able to expand their collaboration and the scope of work being carried out by Physiomics.